受强制性开放获取政策约束的文章 - Dr. Md. Rafi Haider了解详情
无法在其他位置公开访问的文章：5 篇
A review on anticancer potential of bioactive heterocycle quinoline
O Afzal, S Kumar, MR Haider, MR Ali, R Kumar, M Jaggi, S Bawa
European Journal of Medicinal Chemistry 97, 871-910, 2015
强制性开放获取政策： Council of Scientific and Industrial Research, India
"Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
MSA Akhtar, Md Jawaid, Ahsan Ahmed Khan, Zulphikar Ali, Rikeshwer Prasad ...
Bioorganic Chemistry 78, 2018
强制性开放获取政策： Department of Science & Technology, India
Recent progress of benzimidazole hybrids for anticancer potential
MJ Akhtar, MS Yar, VK Sharma, AA Khan, Z Ali, MDR Haider, A Pathak
Current Medicinal Chemistry 27 (35), 5970-6014, 2020
强制性开放获取政策： Department of Science & Technology, India
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review
K Haider, A Pathak, A Rohilla, MR Haider, K Ahmad, MS Yar
European journal of medicinal chemistry 184, 111773, 2019
强制性开放获取政策： Department of Science & Technology, India
Recent advances in the synthesis and anticancer activity of some molecules other than nitrogen containing heterocyclic moeities
MJ Akhtar, MS Yar, AA Khan, Z Ali, MR Haider
Mini Reviews in Medicinal Chemistry 17 (17), 1602-1632, 2017
强制性开放获取政策： Department of Science & Technology, India
可在其他位置公开访问的文章：1 篇
Free radical scavengers: An overview on heterocyclic advances and medicinal prospects
K Haider, MR Haider, K Neha, MS Yar
European Journal of Medicinal Chemistry 204, 112607, 2020
强制性开放获取政策： Department of Science & Technology, India
出版信息和资助信息由计算机程序自动确定